About Herduo 250mg Tablet
Discover the distinguished Herduo 250mg Tablet, a featured solution designed for resplendent results in oncology care. Each majestic box contains 30 yellow, film-coated tablets, expertly composed of Lapatinib (250mg), developed for the advanced treatment of breast cancer. With notable savings and hospital-pharmacy availability, Herduo is strictly prescription-based and taken orally, ensuring patient convenience and safety. Originating from India, this product is presented in robust box/blister packaging, with a shelf life of 24 months, and must be stored in a dry, cool environment to maintain its efficacy. Explore proven cancer treatment with unmatched stability!
Exceptional Usage Profile in Oncology
Herduo 250mg Tablet is primarily used in the treatment of breast cancer, classified under the ATC code L01XE07. Featured for oral administration, it is prescribed strictly for oncology patients and commercially supplied to hospitals, pharmacies, and cancer centers. Widely recognized for its effectiveness, Herduo is used as a pivotal drug in cancer therapy, ensuring patients achieve optimal health outcomes under professional supervision through licensed distributors and suppliers across India.
Export Sampling, Policy & International Outreach
Herduo 250mg Tablet samples are available for evaluation purposes, enabling traders and healthcare professionals to explore its distinguished therapeutic value before placing bulk orders. Samples may be requested at a nominal asking price, with the rate and freight charges clearly outlined in our transparent sample policy. Our main export markets include Asia, Africa, and the Middle East, ensuring global access to quality oncology solutions. Rate inquiries can be facilitated through authorized distributors and agents worldwide.
FAQ's of Herduo 250mg Tablet:
Q: How should Herduo 250mg Tablet be stored for optimal efficacy?
A: Herduo 250mg Tablets should be stored at room temperature in a dry, cool place, away from direct sunlight and moisture to preserve its quality and effectiveness.
Q: What is the main indication for using Herduo 250mg Tablet?
A: Herduo 250mg Tablet is principally indicated for the treatment of breast cancer and is typically used in oncology under prescription guidance.
Q: When is Herduo 250mg Tablet administered during cancer therapy?
A: Herduo 250mg Tablet is generally administered as part of a targeted cancer therapy regimen, exactly as prescribed by a qualified oncologist and based on individual treatment needs.
Q: Where can Herduo 250mg Tablet be obtained?
A: Herduo 250mg Tablet is available through hospital and pharmacy supplies, distributed by authorized distributors, suppliers, and traders across India and select international markets.
Q: What are the main benefits of using Herduo 250mg Tablet in oncology?
A: The primary benefit of Herduo 250mg Tablet is its clinical effectiveness in managing breast cancer, allowing for targeted therapy with proven results and convenient oral administration.